Molina Healthcare, Inc $MOH Shares Purchased by Aberdeen Group plc

Key Points

• Aberdeen Group plc increased its stake in Molina Healthcare by 43.9% in Q4 to 195,064 shares (about 0.36% of the company) valued at approximately $33.85 million, and overall institutional ownership stands at roughly 98.50% with other large additions from AQR, Victory and UBS.
• Molina reported a substantial quarterly earnings miss, posting EPS of ($2.75) versus a $0.43 consensus while revenue rose 8.3% to $11.38 billion, beating sales estimates but missing on profitability.
• Analysts maintain a consensus "Hold" rating with a $169.21 price target; the stock recently traded near $139.26 with a market cap of about $7.25 billion and a 12‑month range of $121.06–$359.97.

Aberdeen Group plc grew its position in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 43.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 195,064 shares of the company's stock after acquiring an additional 59,498 shares during the quarter. Aberdeen Group plc owned about 0.36% of Molina Healthcare worth $33,851,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the business. AQR Capital Management LLC grew its position in Molina Healthcare by 217.0% during the 3rd quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company's stock worth $561,475,000 after purchasing an additional 2,008,458 shares during the last quarter. Victory Capital Management Inc. raised its holdings in shares of Molina Healthcare by 344.3% in the third quarter. Victory Capital Management Inc. now owns 963,526 shares of the company's stock valued at $184,380,000 after buying an additional 746,639 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Molina Healthcare by 31.0% during the third quarter. Dimensional Fund Advisors LP now owns 938,677 shares of the company's stock worth $179,632,000 after buying an additional 222,346 shares during the period. UBS Group AG grew its holdings in shares of Molina Healthcare by 320.7% during the third quarter. UBS Group AG now owns 603,934 shares of the company's stock worth $115,569,000 after buying an additional 460,372 shares during the last quarter. Finally, Northern Trust Corp grew its holdings in shares of Molina Healthcare by 4.9% during the third quarter. Northern Trust Corp now owns 569,023 shares of the company's stock worth $108,888,000 after buying an additional 26,355 shares during the last quarter. 98.50% of the stock is owned by institutional investors and hedge funds.

Molina Healthcare Price Performance

Shares of NYSE:MOH opened at $139.26 on Friday. The firm has a market capitalization of $7.25 billion, a price-to-earnings ratio of 16.27 and a beta of 0.55. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.69 and a quick ratio of 1.69. The business's 50 day simple moving average is $148.98 and its 200-day simple moving average is $163.02. Molina Healthcare, Inc has a 12 month low of $121.06 and a 12 month high of $359.97.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings data on Thursday, February 5th. The company reported ($2.75) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.43 by ($3.18). Molina Healthcare had a return on equity of 13.60% and a net margin of 1.04%.The firm had revenue of $11.38 billion for the quarter, compared to analyst estimates of $10.90 billion. During the same period in the prior year, the firm posted $5.05 earnings per share. The business's revenue for the quarter was up 8.3% compared to the same quarter last year. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, equities analysts forecast that Molina Healthcare, Inc will post 24.4 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

MOH has been the topic of several recent research reports. Wells Fargo & Company set a $141.00 price target on Molina Healthcare and gave the company an "equal weight" rating in a research report on Friday, February 20th. Cantor Fitzgerald lowered their target price on Molina Healthcare from $180.00 to $144.00 and set a "neutral" rating on the stock in a research note on Monday, February 9th. Mizuho dropped their target price on Molina Healthcare from $220.00 to $180.00 and set an "outperform" rating on the stock in a report on Thursday, March 12th. Deutsche Bank Aktiengesellschaft set a $310.00 price target on Molina Healthcare in a research note on Friday, March 13th. Finally, Truist Financial decreased their price target on Molina Healthcare from $190.00 to $145.00 and set a "hold" rating for the company in a report on Tuesday, February 17th. Two research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, Molina Healthcare presently has a consensus rating of "Hold" and a consensus price target of $169.21.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.

Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.